BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19591229)

  • 1. Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible.
    Barzilay R; Melamed E; Offen D
    Stem Cells; 2009 Oct; 27(10):2509-15. PubMed ID: 19591229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.
    Phinney DG; Prockop DJ
    Stem Cells; 2007 Nov; 25(11):2896-902. PubMed ID: 17901396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation.
    Deng J; Petersen BE; Steindler DA; Jorgensen ML; Laywell ED
    Stem Cells; 2006 Apr; 24(4):1054-64. PubMed ID: 16322639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In utero transplantation of human bone marrow-derived multipotent mesenchymal stem cells in mice.
    Chou SH; Kuo TK; Liu M; Lee OK
    J Orthop Res; 2006 Mar; 24(3):301-12. PubMed ID: 16482576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera?
    Tonti GA; Mannello F
    Int J Dev Biol; 2008; 52(8):1023-32. PubMed ID: 18956335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein aggregate-containing neuron-like cells are differentiated from bone marrow mesenchymal stem cells from mice with neurofilament light subunit gene deficiency.
    Chao YX; He BP; Cao Q; Tay SS
    Neurosci Lett; 2007 May; 417(3):240-5. PubMed ID: 17395374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural transdifferentiation of mesenchymal stem cells--a critical review.
    Krabbe C; Zimmer J; Meyer M
    APMIS; 2005; 113(11-12):831-44. PubMed ID: 16480453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regenerative and immunomodulatory potential of mesenchymal stem cells.
    Krampera M; Pasini A; Pizzolo G; Cosmi L; Romagnani S; Annunziato F
    Curr Opin Pharmacol; 2006 Aug; 6(4):435-41. PubMed ID: 16777484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray analyses of transdifferentiated mesenchymal stem cells.
    Schilling T; Küffner R; Klein-Hitpass L; Zimmer R; Jakob F; Schütze N
    J Cell Biochem; 2008 Feb; 103(2):413-33. PubMed ID: 17610236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of multipotent differentiation potentials of murine primary bone marrow stromal cells and mesenchymal stem cell line C3H10T1/2.
    Zhao L; Li G; Chan KM; Wang Y; Tang PF
    Calcif Tissue Int; 2009 Jan; 84(1):56-64. PubMed ID: 19052794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and molecular characterization of hepatocyte-like cells derived from human bone marrow mesenchymal stem cells on a novel three-dimensional biocompatible nanofibrous scaffold.
    Kazemnejad S; Allameh A; Soleimani M; Gharehbaghian A; Mohammadi Y; Amirizadeh N; Jazayery M
    J Gastroenterol Hepatol; 2009 Feb; 24(2):278-87. PubMed ID: 18752558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of genetically modified mesenchymal stem cells.
    Kumar S; Chanda D; Ponnazhagan S
    Gene Ther; 2008 May; 15(10):711-5. PubMed ID: 18356815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological properties of mesenchymal stem cells and clinical implications.
    Patel SA; Sherman L; Munoz J; Rameshwar P
    Arch Immunol Ther Exp (Warsz); 2008; 56(1):1-8. PubMed ID: 18250975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migration, fate and in vivo imaging of adult stem cells in the CNS.
    Syková E; Jendelová P
    Cell Death Differ; 2007 Jul; 14(7):1336-42. PubMed ID: 17396130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells for tissue engineering and regenerative medicine.
    Tae SK; Lee SH; Park JS; Im GI
    Biomed Mater; 2006 Jun; 1(2):63-71. PubMed ID: 18460758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo.
    Conrad C; Niess H; Huss R; Huber S; von Luettichau I; Nelson PJ; Ott HC; Jauch KW; Bruns CJ
    Circulation; 2009 Jan; 119(2):281-9. PubMed ID: 19118255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of mesenchymal stem cell therapy.
    Dazzi F; Horwood NJ
    Curr Opin Oncol; 2007 Nov; 19(6):650-5. PubMed ID: 17906466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells for bone repair: preclinical studies and potential orthopedic applications.
    Arinzeh TL
    Foot Ankle Clin; 2005 Dec; 10(4):651-65, viii. PubMed ID: 16297825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of stem cell differentiation in diabetic rats transplanted with bone marrow mesenchymal stem cells.
    Lin P; Chen L; Yang N; Sun Y; Xu YX
    Transplant Proc; 2009 Jun; 41(5):1891-3. PubMed ID: 19545751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically modified mesenchymal stem cells and their clinical potential in acute cardiovascular disease.
    Griffin M; Greiser U; Barry F; O'Brien T; Ritter T
    Discov Med; 2010 Mar; 9(46):219-23. PubMed ID: 20350488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.